BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32972783)

  • 1. The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes.
    Chino J; Annunziata CM; Beriwal S; Bradfield L; Erickson BA; Fields EC; Fitch J; Harkenrider MM; Holschneider CH; Kamrava M; Leung E; Lin LL; Mayadev JS; Morcos M; Nwachukwu C; Petereit D; Viswanathan AN
    Gynecol Oncol; 2020 Dec; 159(3):607-610. PubMed ID: 32972783
    [No Abstract]   [Full Text] [Related]  

  • 2. ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology.
    Gaffney DK; Erickson-Wittmann BA; Jhingran A; Mayr NA; Puthawala AA; Moore D; Rao GG; Small W; Varia MA; Wolfson AH; Yashar CM; Yuh W; Cardenes HR
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):609-14. PubMed ID: 21215531
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
    Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
    BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor budding in cervical cancer as a prognostic factor and its possible role as an additional intermediate-risk factor.
    Park JY; Chong GO; Park JY; Chung D; Lee YH; Lee HJ; Hong DG; Han HS; Lee YS
    Gynecol Oncol; 2020 Oct; 159(1):157-163. PubMed ID: 32741542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2).
    Akhavan S; Alibakhshi A; Parsapoor M; Alipour A; Rezayof E
    BMC Cancer; 2021 Jun; 21(1):667. PubMed ID: 34088300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
    Koh WJ; Abu-Rustum NR; Bean S; Bradley K; Campos SM; Cho KR; Chon HS; Chu C; Clark R; Cohn D; Crispens MA; Damast S; Dorigo O; Eifel PJ; Fisher CM; Frederick P; Gaffney DK; Han E; Huh WK; Lurain JR; Mariani A; Mutch D; Nagel C; Nekhlyudov L; Fader AN; Remmenga SW; Reynolds RK; Tillmanns T; Ueda S; Wyse E; Yashar CM; McMillian NR; Scavone JL
    J Natl Compr Canc Netw; 2019 Jan; 17(1):64-84. PubMed ID: 30659131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel.
    Kozak MM; Koenig JL; von Eyben R; Kidd EA
    Pract Radiat Oncol; 2019 Mar; 9(2):e164-e171. PubMed ID: 30395974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
    Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
    Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The guidelines for diagnostics and treatment of cervical cancer].
    Inciūra A; Juozaityte E
    Medicina (Kaunas); 2004; 40(4):394-403. PubMed ID: 15111756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
    Höckel M; Hentschel B; Horn LC
    Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
    Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
    Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative chemoradiotherapy versus radiotherapy alone for cervical cancer: A systematic review and meta-analysis.
    Yang J; Yin J; Yan G; Huang D; Wang J
    J Obstet Gynaecol; 2016 Jul; 36(5):641-8. PubMed ID: 26821995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Postoperatively conformed effectiveness of preoperative radio therapy, combined with chemotherapy - cysplatin].
    Lazarov N; Lazarov L; Lazarov S
    Akush Ginekol (Sofiia); 2012; 51(1):52-3. PubMed ID: 22639781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PROGNOSTIC GROUPS FOR RELAPSE IN STAGE IB1 CERVICAL CANCER].
    Ismail E; Kornovski Y; Ivanov S
    Akush Ginekol (Sofiia); 2015; 54(6):28-34. PubMed ID: 26817260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of results and complications of 2 methods of treatment of stage Ib cervical cancer: exclusive radiotherapy and combined treatment. I. Results of 5-years' observation of patients treated in 1973-1977].
    Kietlińska Z
    Nowotwory; 1984; 34(3):201-12. PubMed ID: 6531219
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of stage I and II uterine cervix cancer. Round table].
    Dargent D; Durand JC; Michel G; Pourquier H; Rudigoz RC; Senèze J
    Rev Fr Gynecol Obstet; 1985 Apr; 80(5):299-322. PubMed ID: 4023538
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer.
    Rogers L; Siu SS; Luesley D; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007583. PubMed ID: 19821430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.
    Gemer O; Lavie O; Gdalevich M; Eitan R; Mamanov E; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Meirovitz A; Shachar IB; Arie AB
    Am J Clin Oncol; 2016 Feb; 39(1):37-42. PubMed ID: 25734407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for adjuvant hysterectomy after suboptimal concurrent chemoradiation in cervical carcinoma?
    Walji N; Chue AL; Yap C; Rogers LJ; El-Modir A; Chan KK; Singh K; Fernando IN
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):140-6. PubMed ID: 20045300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.